FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: Important role in exclusion of transplant candidacy

Clinical Nuclear Medicine

Volumn 30, Issue 6, 2005, Pages 408-410

  Kurtovic, Jelica ^a   Van Der Wall, Hans ^b   Riordan, Stephen M ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Hepatocellular carcinoma; Portal vein thrombosis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PORTAL VEIN THROMBOSIS; POSITRON EMISSION TOMOGRAPHY; THROMBUS; TUMOR; TUMOR THROMBUS;

ADULT; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; THROMBOSIS;

EID: 19544388943     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000162606.83862.a7     Document Type: Article

References (10)

1. Riordan SM, Williams R. Preoperative investigation and indication for operation in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 1998;5:l-6.
2. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394-1403.
3. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389-394.
4. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multi-modal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimetres. Ann Surg. 2002; 235:533-539.
5. Schaffer RL III, Kulkarni S, Harper A, et al. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience. Liver Transpl. 2003;9:1211-1215.
6. Roberts JP. Role of adult living liver donation in patients with hepatocellular cancer. Liver Transpl. 2003;9(suppl 2):S60-S63.
7. Sarasin FP, Majno PF, Llovet JM, et al. Living donor liver transplantation for early hepatocellular carcinoma: a life expectancy and cost-effectiveness perspective. Hepatology. 2001;33:1073-1079.
8. Nonami T, Yokoyama I, Iwatsuki S, et al. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992;16:1195-1198.
9. Jeng LB, Changlai SP, Shen YY, et al. Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterohgy. 2003; 50:2154-2156.
10. Trojan J, Schroeder O, Raedle J, et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol. 1999;94:3314-3319.